SK Biopharm Q3 operating profit rises 66 pct on U.S. sales
SK Biopharmaceuticals reported a 65.9 percent increase in third-quarter operating profit to 116.3 billion won, driven by strong U.S. sales of its seizure m
SK Biopharmaceuticals reported a 65.9 percent increase in third-quarter operating profit to 116.3 billion won, driven by strong U.S. sales of its seizure m